Women's and Children's Health Outcomes

Women's and Children's Health programs offer cost savings and improvements in patient compliance. Below is a sampling of Matria's best program-specific outcomes.

Obstetrical Diabetes | Obstetrical Hypertension | Nausea and Vomiting | Preterm Labor | Maternalink®

Obstetrical Diabetes Outcomes

In an internal study of 2,000 patients conducted from 2000 to 2004, Matria produced the followed results for insulin-dependant and non-insulin requiring patients:

Gestational diabetes (non-insulin):

Admitted only 9.4 percent of newborns to the neonatal intensive care unit born to women with gestational diabetes, a significant drop from a benchmark study[1] in which 25 percent of neonates born to women receiving conventional treatment were admitted
In less than one week, the number of patients complying with blood-glucose testing increased from 8.5 percent to 87 percent

Pregestational diabetes (insulin dependant):

33.6 percent reduction in out-of-target blood glucose levels
100 percent improvement in compliance with blood glucose testing
51 percent reduction in the number of Type 2 diabetes patients with A1C greater than 6 percent

Obstetrical Hypertension Outcomes

Findings in a cost analysis showed that outpatient versus inpatient management of hypertension during pregnancy yields similar maternal fetal outcomes, though with significantly fewer maternal antepartum hospital days. The study compared one group of women using Matria's services to one group not using Matria.[2]

The average number of hospital days for women in the Matria group was 1.7 compared to 12.4 for the non-Matria group.
Inpatient and outpatient costs combined were $9,533 for the Matria group versus $19,180 for the non-Matria group.

Nausea and Vomiting Outcomes

Results from a study[3] published November 2004 in Managed Care magazine showed that Matria's NVP program reduced NVP symptoms for 382 out of the 428 women receiving outpatient treatment via subcutaneous pump prescribed by their physician from 2000 to 2002.

Other results:

78 percent increase in weight gain or stabilization
89 percent reduction in nausea and vomiting symptoms
Decrease in the number of people admitted to the hospital before Matria's NVP program from 65.4 percent to 3.3 percent

Preterm Labor Outcomes

Matria showed substantial costs savings in an internal study of 32,557 patients with singleton and twin gestations using Matria's pump and monitoring services from 1999 to 2003.

For every dollar spent on Matria's homecare services, $3.30 was saved.
An average of $13,000 was saved per pregnancy, including the program cost.
Matria saved $156 million in antenatal hospital admissions.

Maternalink Outcomes

The number of days infants born to women participating in Matria's MaternaLink^® Obstetrical Disease Management Program needed to stay in the NICU in the year 2002 was 37 percent below the national plan average of 1,614 NICU days per 1,000 births.

Additionally, the percentage of very low birth weight infants was 0.7 percent, while the national average was 1.1 percent. Likewise, low birth weight infants comprised 4.6 percent of total MaternaLink births, compared to the national average of 6.1 percent. Similar reductions were observed in years 2001 and 2000, translating into a cost savings of $43 million during the three-year period.

[1] Langer O, Rodriguez DA, et al, Intensified versus conventional management of gestational diabetes, American Journal of Obstetrical Gynecology, 1994; 170(4): 1036-47.

[2] Barton JR, Stanziano GJ, Sibai BM, Monitored outpatient management of mild gestational hypertension remote from term, American Journal of Obstetrical Gynecology, 1994; 170:765-9.

[3] David G. Lombardi, MD, Niki B. Istwan, RN, Debbie J. Rhea, MPH, John M. O'Brien, MD, John R. Barton, MD, University of Kentucky, Department of Obstetrics and Gynecology, Lexington, Ky.; Matria Healthcare, Department of Clinical Research, Marietta, Ga.; Central Baptist Hospital, Division of Maternal-Fetal Medicine, Lexington, Ky.